NIH R01 · 2024
PROJECT SUMMARY Pancreatic cancer (PC) is a significant public health issue and is the third leading cause of cancer deaths in the U.S. PC is associated with significant neurologic and psychiatric morbidities, which are associated with reduced health-related quality of life (HRQoL). Supportive care medications (SCM) are the foundation to managing PC- related neurologic and psychiatric symptoms and thus improving HRQoL. Multiple PC studies have demonstrated worsened HRQoL in racial/ethnic minorities. Prior research evaluating the impact of race/ethnicity on SCM use in cancer indicated that racial/ethnic minorities were less likely to be prescribed several types of SCM. However, the studies…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.